Anne Samuel

Stock Analyst at JP Morgan

(1.24)
# 1877
Out of 5,370 analysts
81
Total ratings
42.50%
Success rate
11.41%
Average return
20 Stocks
Name Action PT Current % Upside Ratings Updated
DOCS Doximity
Maintains: Neutral
63 60
56.02 7.1% 6 May 27, 2025
IQV IQVIA Hldgs
Maintains: Overweight
232 177
159.4 11.04% 7 May 19, 2025
OMCL Omnicell
Maintains: Neutral
44 36
29.17 23.41% 5 Mar 20, 2025
VEEV Veeva Systems
Maintains: Neutral
218 249
283.66 -12.22% 6 Mar 20, 2025
EVH Evolent Health
Maintains: Overweight
13 12
8.17 46.88% 12 Mar 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
17 23
21.02 9.42% 7 Jan 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
27 28
25.9 8.11% 2 Sep 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
21 19
22.27 -14.68% 4 Sep 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
19 21
22.27 -5.7% 3 Sep 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
10 13
3.88 235.05% 3 Sep 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
24 27
38.62 -30.09% 2 Aug 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
7 5
3.75 33.33% 1 Jul 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
86 108
101.03 6.9% 7 Apr 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
20 11
n/a n/a 3 Dec 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
30 25
n/a n/a 1 Dec 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
19 20
n/a n/a 1 Nov 18, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
32 31
n/a n/a 2 Sep 6, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
12
n/a n/a 1 Jul 12, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
14 15
n/a n/a 4 Apr 24, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
148 159
n/a n/a 4 Apr 24, 2018